SIDE EFFECTS OF ANTIARRHYTHMIC DRUGS AND THE RELEVANCE OF SEARCHING FOR LOW-TOXICITY ANTIARRHYTHMIC AGENTS

Authors

  • Tolmas Khamroev Tolibovich,Sarvinoz Abdumalikova Akmal qizi, Kamola Shavkat qizi Akramova,Dilnozakhon Bakhtiyor qizi Ashuralieva, Farangiz Erkinova Khasan qizi Assitant of Department of pharmacology of Tashkent State Medical University Student of group 303A of the 3rd Faculty General Medicine of Tashkent State Medical University Author
  • Zulfiya Anvar qizi Khamdamova, Maryam Pardaeva Daminbek qizi2, Munisa Orzikul qizi To‘ychieva, Abdullokh Bunyodovich Yuldashev Author

Keywords:

Mechanisms, pharmacology, drug interactions, arrhythmia, atrial fibrillation, adverse drug responses, anti-arrhythmic medications, anti-arrhythmic drug combinations, Arrhythmias of the ventricles

Abstract

Clinical pharmacology for arrhythmias has not much improved over the past few decades, despite recent years of intensive research on antiarrhythmic medications (AAD). It appears that interventional therapy was prioritized over AAD. However, fresh information on the effectiveness and safety of "classical" molecules makes it necessary to create a useful manual to enhance clinical judgment. Even though many guidelines include suggestions for treating AAD, clinical practice may frequently involve overtreatment or undertreatment.1, 2 Furthermore, because of their narrow therapeutic index, complicated drug-drug interactions, and serious cardiac and extracardiac side effects, AADs are not a neutral medication in terms of safety. There is still a gap between the conventional AADs currently used in clinical practice and the "future" AADs, despite significant current research efforts to find target-specific AADs with better safety margins. Compared to other treatment modalities, antiarrhythmic pharmacologic therapy is one of the clinical domains where evidence-based cardiology is less applied. Many doctors rely on the simplistic Singh-Vaughan Williams classification, which has little clinical significance. A position paper on AAD seems warranted after all these years. Our goal is to provide a useful guide for general cardiologists, internal medicine specialists, general practitioners, and cardiology fellows or residents based on current knowledge and specific recommendations rather than a new pharmacology textbook or a review of research viewpoints. PubMed, MEDLINE, and the Cochrane Library (which includes the Cochrane Database of Systematic Reviews and the Cochrane Controlled Trials Registry) were the databases searched for relevant literature. The English-language sources and research with human participants were the main focus. Only where information was crucial to comprehending pathophysiological principles relevant to patient care and similar data from human studies were unavailable were articles pertaining to animal trials cited. When needed, the writers were asked for more details.

References

1.Peter R. Kowey and Gerald V. Naccarelli. Antiarrhythmic Drug Therapy: Where Do We Go From Here, Circulation, volume = 149, number = 11, pages = 801-803, year = 2024, doi = 10.1161/CIRCULATIONAHA.123.066989

2.Farah Olleik,Peter R. Kowey,Advances in Antiarrhythmic Drug Therapy, Cardiac Electrophysiology Clinics, 18, 1, (109-116), (2026). https://doi.org/10.1016/j.ccep.2025.10.006

3.Jiahao Xie,Jingwen Xu,Qi Fan,Yuchi Chen,Anti-Inflammatory Mechanisms and Translational Relevance of Cordyceps sinensis and Its Bioactive Constituents, Journal of Inflammation Research, Volume 19, (1-22), (2026). https://doi.org/10.2147/JIR.S582921

4.Ruben Vardanyan,Gayane Vardanyan,Antiarrhythmic drugs, Synthesis of Best-Seller Drugs, (433-447), (2026). https://doi.org/10.1016/B978-0-443-33869-4.00008-9

5.Aripov A.N., Aripov O.A., Akhundjanova L.L., Nabiev A.U., Nabieva D.A., & Khamroev T.T. (2022). Study the effect of yantacin on some indicators of cellular renewal and on the level of protein expression on rat hepatocytes in chronic heliotrine liver damage. International Journal of Medical Sciences And Clinical Research, 2(05), 06–13. https://doi.org/10.37547/ijmscr/Volume02Issue05-02.

6.Aripov A. N, Akhunzhanova L. L, Nabiev A. U, Aripov A. O, Khamroev T. T.. Antifibrotic Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, Lycopene and Proanthacyanidin in Experimental Severe Chronic Hepatitis Compared with Phosphogliv. Biomed Pharmacol J 2023;16(3).Pages : 1815-1825. DOI : https://dx.doi.org/10.13005/bpj/2761

7.Aripov A.N, Akhunjanova L.L, Khamroev T.T, Aripov Abdumalik Nigmatovich, Akhunjanova Lola Lazizovna, & Khamroev Tolmas Tolibovich. (2022). Differential Analysis of Chronic Toxic Hepatitis Caused by The Introduction of Heliotrin Solution in Various Ways. Texas Journal of Medical Science, 4, 58–62. Retrieved from https://zienjournals.com/index.php/tjms/article/view/670

8.Rashidov S.Z., Rakhimboev S.D., Sanoev Z.I., Abdinazarov I.T., Khamroev T.T., Ismailova D.S., & Elmuradov B.J.. (2022). Study of psychoactive activity potassium salt 5-(o-aminophenyl)-1,3,4- oxadiazole-2-thion (D-361). International Journal of Medical Sciences And Clinical Research, 2(09), 1–5. https://doi.org/10.37547/ijmscr/Volume02Issue09-01

9.Арипов А.Н., Арипов О.А., Ахунджанова Л.Л., Набиев А.Ў., Нишанбаев С.З., Набиева Д.А., Ҳамроев Т.Т. Тажриба шароитида сафорофлавонолозиднинг гепатотроп фаоллигини ўрганиш. Oriental Journal of Medicine and Pharmacology, 2(02), 55–64. https://doi.org/10.37547/supsci-ojmp-02-02-07

10.Zakhidova L.T., Saidkhodjaeva D.M., Sanoev Z.I., Tukhtasheva V.F., Rakhmanova H.A.., Hamroyev T.T. Toxicological Characteristics Of N-Deacetyllappaconitine Under Chronic Administration In White Rats. The American Journal of Applied Sciences, 3(03), 34-41. https://doi.org/10.37547/tajas/Volume03Issue03-06

11.Khamroev T.T., Sanoev Z.I., Rakhimboev S.D., Abdinazarov I.T., Rashidov S.Z. Effect of antiarrhythmic substance N – dezacetyllapoconitin on the central nervous system. ISJ Theoretical &Applied Science, 07 (99), 153-157. http://soi.org/1.1/TAS-07-99-31 Doi:https://dx.doi.org/10.15863

12.Sanoev Z. I, Ismailova D. S, Rakhimboev S. D. O, Khamroev T, T, Elmuradov B. Z, Abdinazarov I. T, Rashidov S. Z. O. Synthesis and Research Anticonvulsant Activity of Annulated Triazolo-Thiadiazine Derivative in Laboratory Animals. Biomed Pharmacol J 2023;16(4). DOI : https://dx.doi.org/10.13005/bpj/2820

13.Sokhib Rashidov Zamon oʻgʻli, Muslimakhon Kamolova Mirzokhidjon qizi, Ikhvoliddin Mirzaev Komiljon o‘g‘li, Nodira Pardaeva Botir qizi, Sevara Rakhmatullaeva Shukhrat qizi/. (2025). The importance of cardiotonic drugs in medical practice, the range of applications and the advantages of their use. International Journal of Cognitive Neuroscience and Psychology, 3(5), 95–100. Retrieved from https://medicaljournals.eu/index.php/IJCNP/article/view/1856

14.Sanoev Zafar Isomiddinovich, Rashidov Sokhib Zamon ugli, Raximboev Sukhrob Davlatyor ugli, Abdinazarov Ibrokhim Tuychievich, Khamroev Tolmas Tolibovich, Ismailova Dilnoza Safaralievna, & Elmuradov Burkhon Juraevich. (2022). Research of Anticonvulsant Activity of Compound 5- (P-Aminophenyl) - 1,3,4-Oxadiazole-2-Thion. Texas Journal of Medical Science, 13, 17–21. Retrieved from https://zienjournals.com/index.php/tjms/article/view/2434

15.Yu. R. Mirzaev, T. T. Khamroev, E. M. Ruzimov, B. N. Khandamov, & Sh. M. Adizov. (2022). Evaluation of the Effect on the Nervous System of Substances with an Alkaloid Structure Having Antitumor Activity. Journal Healthcare Treatment Development(JHTD) ISSN : 2799-1148, 2(06), 6–10. Retrieved from http://journal.hmjournals.com/index.php/JHTD/article/view/1577

16.Aripov A.N., Aripov O.A., Akhunjanova L.L., Nabiev A.O., Nabieva D.A., & Khamroev T.T. (2022). Study the antifibrous efficacy of plant proanthocyanidin in rats with chronic heliotrine liver damage. Frontline Medical Sciences and Pharmaceutical Journal, 2(05), 16–25. https://doi.org/10.37547/medical-fmspj-02-05-03.

17.Sokhib Rashidov Zamon oʻgʻli, Nilufar Ergasheva Agʼzamjon qizi, Elyor Zokirboyev Anvarjon o‘gli, Umidjon Akramov Abdusamad o‘g‘li, & Aziza Egamberdieva Farkhod qizi. (2025). Drugs That Increase the Tone of the Human Body and Pharmacological Characteristics of Immunodeficiency Agents. American Journal of Biomedicine and Pharmacy, 2(5), 300–306. Retrieved from https://biojournals.us/index.php/AJBP/article/view/1065

18.Sokhib Rashidov Zamon oʻgʻli, Murodjon Nabiev Mahammadkarim o‘g‘li, Mo'tabar Yoqubjonova Khusanboy qizi, Shakhzodakhon Bekmurodova Poʻlatjon qizi, & Jumanazar To‘ychiev Saidqul o‘g‘li. (2025). Comparative Analysis of Drugs Used for Anemia and Drugs Storing Iron. Research Journal of Trauma and Disability Studies, 4(5), 190–195. Retrieved from https://journals.academiczone.net/index.php/rjtds/article/view/5141

19.Sokhib Rashidov Zamon oʻgʻli, Shakhzoda Abduraimova Abdusattor qizi, Nigora Yusufjonova Mirrakhim qizi, Diyora Turdibekova Erkinjon qizi, & Makhsuma Dovutkho’jayeva Maqsudjonovna. (2025). Classification, Indications for Use, Range of Applications and Disadvantages of Medicines against Nematodes and Leishmania. Research Journal of Trauma and Disability Studies, 4(5), 196–201. Retrieved from https://journals.academiczone.net/index.php/rjtds/article/view/5142

20.Sokhib Rashidov Zamon oʻgʻli, Nigora Yusufjonova Mirrakhim qizi, Diyora Turdibekova Erkinjon qizi, Makhsuma Dovutkho’jaeva Maqsudjonovna, Shakhzoda Abduraimova Abdusattor qizi, Analysis of the effect of medicines used in medical practice for various diseases on the fetus , european journal of modern medicine and practice: Vol. 5 No. 5 (2025) 342-347.

21.Sokhib Rashidov Zamon oʻgʻli, Elyor Zokirboev Anvarjon ògli, Umidjon Akramov Abdusamad o‘g‘li, Aziza Egamberdiyeva Farkhod qizi, Munisa Qoʻshbekova Roʻzimbek qizi. (2025). Analysis of general and specific pharmacological properties of fat-soluble vitamins. International Journal of Cognitive Neuroscience and Psychology, 3(5), 101–106. Retrieved from https://medicaljournals.eu/index.php/IJCNP/article/view/1857

22.Gheorghe-Andrei Dan, Antoni Martinez-Rubio, Stefan Agewall, ey al. ESC Scientific Document Group , Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP), EP Europace, Volume 20, Issue 5, May 2018, Pages 731–732an, https://doi.org/10.1093/europace/eux373

23.Merino JL, Tamargo J, Blomström-Lundqvist C, et al. Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. Europace. 2025 Aug 4;27(8):euaf076. doi: 10.1093/europace/euaf076. Erratum in: Europace. 2026 Mar 10;28(3):euag041. doi: 10.1093/europace/euag041.

24.Allen LaPointe NM, Dai D, Thomas L, Piccini JP, Peterson ED, Al-Khatib SM. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease. Am J Cardiol 2015;115:316–22.

25.Nattel S, Heijman J, Zhou L, Dobrev D. Molecular basis of atrial fibrillation pathophysiology and therapy: a translational perspective. Circ Res 2020;127:51–72.

26.Saksena S, Ken-Opurum J, McKindley DS, Preblick R, Rashkin J, Aldaas OM et al. Arrhythmia recurrence and rhythm control strategies after catheter ablation of newly diagnosed atrial fibrillation (ARRC-AF study). JACC Clin Electrophysiol 2025:S2405-500X(24)01027-2.

27. Chakraborty P, Rose RA, Nair K, Downar E, Nanthakumar K. The rationale for repurposing funny current inhibition for management of ventricular arrhythmia. Heart Rhythm 2021;18:130–7.

28.Fontenla A, Tamargo J, Salgado R, López-Gil M, Mejía E, Matía R et al. Ivabradine for controlling heart rate in permanent atrial fibrillation: a translational clinical trial. Heart Rhythm 2023;20:822–30.

29.Di Marco GM, De Nigris A, Pepe A, Pagano A, Di Nardo G, Tipo V. Ivabradine-flecainide as breakthrough drug combination for congenital junctional ectopic tachycardia: a case report and literature review. Pediatr Rep 2021;13:624–31.

Downloads

Published

2026-05-26